AddLife AB (publ) (FRA:1AD1)

Market Cap	1.50B -6.8%
Revenue (ttm)	964.87M +1.5%
Net Income	51.75M +122.2%
EPS	0.42 +122.8%
Shares Out	n/a
PE Ratio	29.07
Forward PE	30.57
Dividend	0.07 (0.55%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	n/a
Open	12.51
Previous Close	12.43
Day's Range	12.51 - 12.51
52-Week Range	12.30 - 19.01
Beta	n/a
RSI	38.73
Earnings Date	Apr 1, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1906
• Employees: 2,295
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1AD1

Financial Performance

In 2025, AddLife AB's revenue was 10.44 billion, an increase of 1.52% compared to the previous year's 10.29 billion. Earnings were 560.00 million, an increase of 122.22%.

Financial numbers in SEK